At CHEST 2024, Cesar Davila-Chapa, MD, University of Nebraska Medical Center, brings awareness to the racial disparities demonstrated in his investigation of idiopathic pulmonary fibrosis (IPF) hospitalizations and outcomes.
Findings presented at the CHEST 2024 annual meeting last week in Boston, Massachusetts, showed racial differences in outcomes among patients hospitalized with idiopathic pulmonary fibrosis (IPF). Using data from the National Inpatient Sample (NIS; 2016-2019), researchers analyzed 14,815 hospitalizations, where 9.15% of patients were Black and 90.85% were non-Hispanic White.
In an interview with The American Journal of Managed Care® (AJMC®), lead investigator Cesar Davila-Chapa, MD, pulmonary and critical care cochief fellow at the University of Nebraska Medical Center, emphasized that racial disparities persist in IPF hospitalizations and outcomes, underscoring the need for further research to confirm these findings and address inequities in care.
This transcript has been lightly edited for clarity.
Transcript
Can you share the motivation and key findings of the research you presented at CHEST?
We know that racial and ethnic disparities exist, and I wanted to kind of raise awareness as well as see what existence there is, and mostly within hospitalizations of those patients with IPF. In my study, we reviewed the [National Inpatient Sample] database and found many hospitalizations. We wanted to see what the outcomes were in these hospitalizations and what age the patients were first admitted at. And we found that there are disparities that exist in the health care system.
We found that Black patients are admitted at a younger age and non-Hispanic White patients at a later age. There could be many implications that we don't know, specifically at this time, what these implications mean. But it is a mimic of other studies, reinforcing and raising more awareness that there are disparities that exist, and it shows that patients may be sicker at an earlier age. And we are more aware of this because although the study did show that there was a decreased mortality in Black patients versus non-Hispanic White patients, that's only during hospitalizations. We don't know what happens in the outpatient setting. So that's important to know that they're presenting at a younger age.
There was a more pertinent [finding] in terms of there being more female Black patients versus female White patients. That could mean other implications as well. We think it's important to raise awareness to kind of prevent these disparities. And how do we do that? You know, we need to first be aware of what disparities exist.
I think studies like this, whether they're database studies—and they do have limitations—I think it's still important to raise awareness. So that we can move on to the next step with prospective studies, with steps to push our boundaries and push where health care is now and to provide better care and be aware that maybe Black patients can be diagnosed with IPF at a younger age. And that is something to raise awareness in terms of putting in our differential as pulmonary physicians.
Reference
Davila-Chapa C, Thotamgari SR, Chaaban S. Racial differences in hospitalizations for idiopathic pulmonary fibrosis in the United States. CHEST. 2024;166(4):A3814.
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
Rare Autoimmune Disorder Linked With Increased Risk of Certain Skin Cancers
April 21st 2025The risk of some skin cancers, including squamous cell carcinoma, basal cell carcinoma, and non-melanoma skin cancer, was particularly heightened among patients with severe mucous membrane pemphigoid.
Read More